{"id":10069,"date":"2023-06-26T16:01:17","date_gmt":"2023-06-26T14:01:17","guid":{"rendered":"https:\/\/aphp-mobile-web.fr\/applis\/recos-perfusion\/?p=10069"},"modified":"2023-07-04T10:19:08","modified_gmt":"2023-07-04T08:19:08","slug":"page-11","status":"publish","type":"post","link":"https:\/\/aphp-mobile-web.fr\/applis\/recos-perfusion\/page-11\/","title":{"rendered":"11 – Bibliographie"},"content":{"rendered":"\n
\"Bibliographie\"<\/div>\n
\n\nSeules ont \u00e9t\u00e9 cit\u00e9es dans cette bibliographie, les r\u00e9f\u00e9rences ayant servi \u00e0 l\u2019\u00e9laboration de ces recommandations.<\/b>\n
    \n \t
  1. Bonnes pratiques de pr\u00e9paration. Afssaps. 3 d\u00e9cembre 2007.<\/li>\n \t
  2. Simon N. et al. Quantification du volume n\u00e9cessaire pour rincer un circuit de perfusion apr\u00e8s administration d\u2019une chimioth\u00e9rapie anticanc\u00e9reuse. Poster Europharmat Bordeaux 2008.<\/li>\n \t
  3. Billard V., Weil G., Cazala\u00e0 J.B., Meunier L. \u00ab\u202fBonnes pratiques m\u00e9dicales de la perfusion\u202f\u00bb, 2005, Editeur Fr\u00e9s\u00e9nius Vial SAS.<\/li>\n \t
  4. D\u00e9caudin B., Dewulf S., Lannoy D., Simon N., Secq A., Barth\u00e9l\u00e9my C., et al. Impact of multiaccess infusion devices on in vitro drug delivery during multi-infusion therapy. Anesth Analg. oct 2009;109(4):1147-55.<\/li>\n \t
  5. Chambrin PY. Les perfuseurs. Des \u00e9volutions lentes mais continues. Moniteur Hospitalier. 2000\u202f; 125\u202f: 29-38.<\/li>\n \t
  6. Thiveaud D. Les dispositifs de r\u00e9gulation du d\u00e9bit de perfusion par gravit\u00e9, ADPHSO, 1996\u202f; Tome 21 (4): 83-90.<\/li>\n \t
  7. Poulain-Vandamme A.M. et al. Perfusion, r\u00e9gulateurs de d\u00e9bit et s\u00e9curit\u00e9 th\u00e9rapeutique. Journal de Pharmacie clinique. 1991\/09; 10 N\u00b0 3\u202f: 159-166.<\/li>\n \t
  8. Caruba T., Havard L., Gillaizeau F., Gu\u00e9rot E., Prognon P., Pineau J. [Evaluation of flow rate regulators for intravenous infusion]. Ann Fr Anesth\u00e8sie R\u00e8animation. nov 2009;28(11):936-42.<\/li>\n \t
  9. Pr\u00e9cautions d\u2019emploi et recommandations d\u2019utilisation concernant les pompes \u00e0 perfusion et les pousse-seringues en p\u00e9diatrie et en n\u00e9onatologie.<\/a> Agence fran\u00e7aise de s\u00e9curit\u00e9 sanitaire des produits de sant\u00e9. D\u00e9cembre 2009.<\/li>\n \t
  10. Sarraf E., Mandel JE. Time-delay when updating infusion rates in the Graseby 3400 pump results in reduced drug delivery. Anesth Analg. janv 2014;118(1):145-50.<\/li>\n \t
  11. Schmidt N., Saez C., Seri I., Maturana A. Impact of syringe size on the performance of infusion pumps at low flow rates. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. mars 2010;11(2):282-6.<\/li>\n \t
  12. Neal D., Lin JA. The effect of syringe size on reliability and safety of low-flow infusions. Pediatr Crit Care Med J Soc Crit Care Med World Fed Pediatr Intensive Crit Care Soc. sept 2009;10(5):592-6.<\/li>\n \t
  13. Neff SB., Neff TA., Gerber S., Weiss MM. Flow rate, syringe size and architecture are critical to start-up performance of syringe pumps. Eur J Anaesthesiol. juill 2007;24(7):602-8.<\/li>\n \t
  14. Recommandation 55. Pr\u00e9vention des infections li\u00e9es aux cath\u00e9ters veineux p\u00e9riph\u00e9riques. SF2H-HAS. Novembre 2005.<\/li>\n \t
  15. Recommandation 59. Bonnes pratiques et gestions des risques associ\u00e9s au PICC. SF2H. D\u00e9cembre 2013.<\/li>\n \t
  16. Recommandation 70. Pr\u00e9vention des infections associ\u00e9es aux chambres \u00e0 cath\u00e9ter implantables pour acc\u00e8s veineux. SF2H. Mars 2012.<\/li>\n \t
  17. Recommandation 53. Pr\u00e9vention des infections li\u00e9es aux cath\u00e9ters veineux p\u00e9riph\u00e9riques. SF2H-HAS. Novembre 2005.<\/li>\n \t
  18. Recommandation 77. Bonnes pratiques et gestions des risques associ\u00e9s au PICC. SF2H. D\u00e9cembre 2013.<\/li>\n \t
  19. Recommandation 67. Pr\u00e9vention des infections associ\u00e9es aux chambres \u00e0 cath\u00e9ter implantables pour acc\u00e8s veineux. SF2H. Mars 2012.<\/li>\n \t
  20. Recommandation 78. Bonnes pratiques et gestions des risques associ\u00e9s au PICC. SF2H. D\u00e9cembre 2013.<\/li>\n \t
  21. Recommandation 68. Pr\u00e9vention des infections associ\u00e9es aux chambres \u00e0 cath\u00e9ter implantables pour acc\u00e8s veineux. SF2H. Mars 2012.<\/li>\n \t
  22. Recommandation 79. Pr\u00e9vention des infections associ\u00e9es aux chambres \u00e0 cath\u00e9ter implantables pour acc\u00e8s veineux \u2013 SF2H \u2013 mars 2012.<\/li>\n \t
  23. Recommandation 74 \u2013 Pr\u00e9vention des infections associ\u00e9es aux chambres \u00e0 cath\u00e9ter implantables pour acc\u00e8s veineux \u2013 SF2H \u2013 mars 2012.<\/li>\n \t
  24. Recommandation 62 \u2013 Bonnes pratiques et gestion des risques associ\u00e9s au PICC \u2013 SH2H \u2013 d\u00e9cembre 2013.<\/li>\n \t
  25. Esteve F., Pujol M., Lim\u00f3n E., Saballs M., Argerich MJ., Verdaguer R., et al. Bloodstream infection related to catheter connections: a prospective trial of two connection systems. J Hosp Infect. sept 2007;67(1):30-4.<\/li>\n \t
  26. Casey AL., Worthington T., Lambert PA., Quinn D., Faroqui MH., Elliott TSJ. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector. J Hosp Infect. ao\u00fbt 2003;54(4):288-93.<\/li>\n \t
  27. Bouza E., Mu\u00f1oz P., L\u00f3pez-Rodr\u00edguez J., Jes\u00fas P\u00e9rez M., Rinc\u00f3n C., Mart\u00edn Rabad\u00e1n P., et al. A needleless closed system device (CLAVE) protects from intravascular catheter tip and hub colonization: a prospective randomized study. J Hosp Infect. ao\u00fbt 2003;54(4):279-87.<\/li>\n \t
  28. Y\u00e9benes JC., Sauca G., Solsona M., Martinez R., Serra-Prat M., Gil P., et al. Safety of positive-pressure valve connectors in arterial catheters inserted into critically ill patients. J Hosp Infect. d\u00e9c 2008;70(4):341-5.<\/li>\n \t
  29. Y\u00e9benes JC., Vidaur L., Serra-Prat M., Sirvent JM., Batlle J., Motje M., et al. Prevention of catheter-related bloodstream infection in critically ill patients using a disinfectable, needle-free connector: a randomized controlled trial. Am J Infect Control. ao\u00fbt 2004;32(5):291-5.<\/li>\n \t
  30. Casey AL., Burnell S., Whinn H., Worthington T., Faroqui MH., Elliott TSJ. A prospective clinical trial to evaluate the microbial barrier of a needleless connector. J Hosp Infect. mars 2007;65(3):212-8.<\/li>\n \t
  31. O\u2019Grady N., Alexander M. et al. Guidelines for the prevention of intravascular catheter-related infections, 2011. Source<\/a>.<\/li>\n \t
  32. Salgado CD., Chinnes L., Paczesny TH., Cantey JR. Increased rate of catheter-related bloodstream infection associated with use of a needleless mechanical valve device at a long-term acute care hospital. Infect Control Hosp Epidemiol. juin 2007;28(6):684-8.<\/li>\n \t
  33. Maragakis LL., Bradley KL., Song X., Beers C., Miller MR., Cosgrove SE., et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol. janv 2006;27(1):67-70.<\/li>\n \t
  34. Rupp ME., Sholtz LA., Jourdan DR., Marion ND., Tyner LK., Fey PD., et al. Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis Off Publ Infect Dis Soc Am. 1 juin 2007;44(11):1408-14.<\/li>\n \t
  35. Field K., McFarlane C., Cheng AC., Hughes AJ., Jacobs E., Styles K., et al. Incidence of catheter-related bloodstream infection among patients with a needleless, mechanical valve-based intravenous connector in an Australian hematology-oncology unit. Infect Control Hosp Epidemiol. mai 2007;28(5):610-3.<\/li>\n \t
  36. Marschall J., Mermel LA., Fakih M., Hadaway L., Kallen A., O\u2019Grady NP., et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. sept 2014;35 Suppl 2:S89-107.<\/li>\n \t
  37. Pr\u00e9vention des infections associ\u00e9es aux CCI. SFHH. Mars 2012.<\/li>\n \t
  38. Recommandations 78 et 81. Pr\u00e9vention des infections associ\u00e9es aux chambres \u00e0 cath\u00e9ter implantables pour acc\u00e8s veineux. SFHH. Mars 2012.<\/li>\n \t
  39. Recommandation 63. Bonnes pratiques et gestion des risques associ\u00e9s au PICC. SFHH. D\u00e9cembre 2013.<\/li>\n \t
  40. Recommandations HAS avril 2008 sur d\u00e9clenchement artificiel du travail \u00e0 partir de 37 semaines d\u2019am\u00e9norrh\u00e9e.<\/li>\n \t
  41. Merckx J., Ferroni A., Guiffant G., Gaudin F., Durussel JJ., Flaud P. P239: Rin\u00e7age puls\u00e9\u202f: pr\u00e9vention dela colonisation des acc\u00e8s vasculaires. Nutr Clin M\u00e9tabolisme. d\u00e9c 2014;28, Supplement 1:S194.<\/li>\n \t
  42. Site internet\u202f: www.stabilis.org<\/a>, liste consult\u00e9e le 11\/07\/2017.<\/li>\n \t
  43. Fiche de Bonnes Pratiques\u202f: Hydratation par perfusion sous-cutan\u00e9e (hypodermoclyse). OMEDIT R\u00e9gion Centre, juin 2013.<\/li>\n \t
  44. Guide \u00ab\u202fAide \u00e0 la r\u00e9daction d\u2019un document sur la pose, l\u2019entretien et la surveillance d\u2019une perfusion par voie sous-cutan\u00e9e chez l\u2019adulte\u202f\u00bb. CCLIN Ouest. 2013.<\/li>\n \t
  45. Pr\u00e9vention des infections en \u00e9tablissements d\u2019h\u00e9bergement pour personnes \u00e2g\u00e9es d\u00e9pendantes. SFHH juin 2009.<\/li>\n<\/ol>\nNormes :<\/u><\/b>\n